Walgreens Boots Alliance

What Walgreens Boots Alliance does

Walgreens Boots Alliance is a global pharmacy and healthcare services company headquartered in Deerfield, Illinois, operating retail pharmacy chains across the United States (8,000+ Walgreens locations) and the United Kingdom (2,100+ Boots locations). The company serves approximately 9 million daily customers, with 78% of Americans living within 5 miles of a Walgreens and 110 million+ enrolled in the myWalgreens loyalty program. Its business spans prescription dispensing, over-the-counter retail, vaccinations, specialty pharmacy, primary care through VillageMD co-located clinics (1,200+ sites), and home-health coordination through CareCentrix.

The company's technology platform integrates physical pharmacy operations with digital prescription management via mobile app and website, same-day delivery reaching 80%+ of U.S. households, automated micro-fulfillment centers (Minnesota, May 2025), and AI-driven specialty pharmacy analytics that report oncology adherence rates exceeding 90%. Walgreens Advertising Group operates a retail media network enabling CPG brand advertising. The Walgreens Health Connect digital platform extends AI-driven personalization, telehealth, and prescription management into European markets.

Following its August 2025 acquisition by Sycamore Partners for approximately $10 billion, WBA was taken private and restructured into five standalone entities: Walgreens (U.S. retail pharmacy), The Boots Group (UK/international health and beauty), Shields Health Solutions (specialty pharmacy), CareCentrix (home-care coordination), and VillageMD (primary care). The company is now executing a turnaround strategy under new CEO Mike Motz and Executive Chairman John Lederer, including plans to close 1,200 U.S. stores over three years, workforce reductions, and a pivot toward digital-first health-and-deals operations while expanding VillageMD toward a 2,000-site network by 2027.

Name

Walgreens Boots Alliance

Legal name

Walgreens Boots Alliance Inc.

Website

https://walgreensbootsalliance.com

Company type

Private

Founded year

1901

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Walgreens Boots Alliance operates 8,000+ U.S. retail pharmacies and 2,100 UK Boots stores, serving 9 million daily customers with prescription dispensing, specialty pharmacy, VillageMD primary care clinics, and digital health services, now operating as five standalone private entities following Sycamore Partners' August 2025 take-private acquisition.

Ownership category

akta.pro rank

Product category

Retail Pharmacy and Drug Stores

NAICS

Pharmacies and Drug Retailers (456110), Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Discount Drugstores (Value-Focused Chain Pharmacies) (CRAEAHAA)

akta.pro secondary industries

Retail & Community Pharmacies (Chain/Independent) (HLAFALAA), Discount Drugstores with Clinics (Retail Health Clinics) (CRAEAHAE), Discount Drugstores with Front-End General Merchandise (Value GM) (CRAEAHAI)

Keywords

• Retail pharmacy services
• Prescription dispensing
• Specialty pharmacy services
• Primary care clinics
• Health and beauty retail

Headquarters

HQ city

Deerfield

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Prescription Dispensing: Core pharmacy services including prescription filling, verification, and dispensing through Walgreens retail pharmacy stores. Revenue generated from prescription sales to consumers across 8,000+ U.S. locations and 2,100 Boots locations in the UK.
2. Healthcare Services: VillageMD co-located clinics providing primary care, chronic condition management, and immunizations. Healthcare services platform contributes 25% of U.S. revenues (up from 10% in 2022), with analysts projecting service revenues to reach $15 billion by 2028.
3. Retail Products: Over-the-counter medicines, wellness products, health screenings, and general retail items sold through Walgreens and Boots pharmacy locations.
4. Vaccinations and Immunizations: Walgreens pharmacy services include vaccination and immunization services with increasing roles in vaccination programs and chronic disease management.
5. Retail Media Advertising: Walgreens Advertising Group operates as a retail media network, enabling CPG brands and advertisers to reach Walgreens customers through targeted advertising on digital and physical platforms.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Walgreens Boots Alliance operates retail pharmacy stores dispensing prescriptions and selling health, wellness, and beauty products across 8,000+ U.S. locations and 2,100+ Boots locations in the UK. Core offerings include prescription filling, vaccinations, health screenings, specialty pharmacy services through Shields Health Solutions, and primary care via co-located VillageMD clinics. The business is supported by a digital prescription management platform and same-day delivery reaching 80%+ of U.S. households.

Product overview

Walgreens Boots Alliance operates a multi-brand portfolio of pharmacy and health services under a platform-plus-modules architecture. The core offering is Walgreens Retail Pharmacy with over 8,000 U.S. locations serving 9 million daily customers, supported by the Walgreens Mobile Pharmacy App as the digital-first engagement platform. The portfolio includes VillageMD primary care clinics (1,200+ sites contributing 25% of U.S. revenues), Shields Health Solutions specialty pharmacy, CareCentrix home-health coordination, Boots UK health and beauty retail (2,100+ locations), and Walgreens Health Connect digital health platform. Walgreens Advertising Group provides retail media capabilities. Following Sycamore Partners' August 2025 acquisition, the company restructured into five standalone entities: Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD.

Differentiator

Problem solved

Functional benefit

Brands

• Boots: UK health and beauty retail chain and pharmacy brand operating in UK, Ireland, and internationally
• No7 Beauty Company
• Boots Opticians
• Alliance Healthcare

Products and services

• Walgreens Retail Pharmacy Retail pharmacy operations offering prescription filling, vaccinations, health screenings, and retail items across over 8,000 U.S. locations. Features extended hours, drive-thru pharmacy lanes, and digital prescription management tools.
• VillageMD Primary Care Clinics Primary care clinic network with 1,200+ co-located clinic sites providing primary care, chronic condition management, and immunizations inside Walgreens stores. Healthcare services platform contributes 25% of U.S. revenues.
• Shields Health Solutions Specialty Pharmacy Specialty pharmacy company partnering with over 80 health systems and clinics across nearly all 50 U.S. states. Provides management of high-cost treatments for chronic and complex conditions including oncology, neurology, and metabolic conditions.
• CareCentrix Home Care Coordination Post-acute and home care coordination company. Provides home-health services and home-centered care coordination, now operating as a standalone private company under Sycamore Partners ownership.
• Boots UK Health and Beauty Retail UK health and beauty retail chain with 2,100+ locations. Offers pharmacy services, beauty products including No7 Beauty Company brands, optical services through Boots Opticians, and online sales via boots.com with double-digit digital growth in FY2024.
• Walgreens Health Connect Digital Platform Digital health platform featuring AI-driven personalization, telehealth, and prescription management, launched across select European markets (UK, Germany, Austria, Switzerland) to transform retail pharmacy operations with omnichannel capabilities.
• Walgreens Advertising Group Retail media network enabling CPG brands and advertisers to reach Walgreens customers through targeted advertising on digital and physical platforms. Rated highly by CPG brand and agency professionals for targeting effectiveness and ROI.
• Walgreens Specialty Pharmacy AI Analytics Specialty pharmacy analytics platform using AI and branching logic to transform patient care from reactive to proactive across oncology, neurology, and metabolic conditions, achieving oncology adherence rates exceeding 90%.
• Walgreens Mobile Pharmacy App Mobile application for prescription management, digital-first health-and-deals platform, same-day delivery, and pharmacy services. Core component of digital transformation strategy with same-day delivery reaching 80%+ of U.S. households.

Quantifiable outcome

• Oncology adherence rates exceeding 90% through AI-powered proactive patient care model
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• CareCentrixcoreStrategic or Co-development Partner · 31 August 2022Walgreens completed a $330 million majority stake investment in CareCentrix, a post-acute and home care company. CareCentrix operates as a home healthcare coordination firm. Following Sycamore Partners' acquisition of WBA in August 2025, CareCentrix became a standalone private company under Sycamore ownership, returning to its previous ownership structure prior to 2022.
• VillageMDcoreStrategic or Co-development Partner · 14 October 2021Walgreens invested $5.2 billion to increase its stake in VillageMD to approximately 63%. VillageMD operates co-located primary care clinics within Walgreens stores, providing integrated primary care, chronic condition management, and immunizations. The partnership aims to improve patient care through integrated primary care and pharmacy models with a goal of over 2,000 clinics by 2027.

Scale indicators10 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• CVS Health: Largest U.S. retail pharmacy chain with integrated PBM (Caremark), health insurance (Aetna), and primary care (Oak Street, Signify). Directly competes with Walgreens on retail pharmacy, specialty pharmacy, and co-located clinics.
• Rite Aid: U.S. drugstore chain with comparable retail pharmacy footprint and prescription dispensing model. Historically Walgreens' closest direct competitor in the value drugstore segment; recently emerged from bankruptcy.
• Amazon Pharmacy: Online-first pharmacy platform leveraging Amazon's logistics and Prime customer base. Competes with Walgreens on prescription delivery, pricing transparency, and digital-first patient experience.

Broad incumbents

• Walmart Pharmacy: Operates in-store pharmacies across 4,600+ U.S. stores with broad general merchandise footprint. Competes with Walgreens for OTC, prescription pickup, and front-end health and wellness purchases, though pharmacy is not the core business.
• Costco Pharmacy: Operates pharmacy counters inside Costco warehouses with deeply discounted prescription pricing model. Comparable on price-sensitive value pharmacy positioning, though a smaller footprint than Walgreens.
• Kroger Pharmacy: Operates pharmacies inside Kroger supermarkets across the U.S., offering prescription services alongside grocery and general merchandise. Comparable pharmacy-plus-retail model, though anchored in grocery rather than drugstore.
• UnitedHealth Group / Optum Rx: Vertically integrated payer-PBM-pharmacy-services platform that competes with Walgreens on specialty pharmacy, mail-order prescriptions, and value-based primary care via Optum. Sets the reimbursement terms that drive Walgreens' pharmacy economics.
• McKesson: Largest U.S. pharmaceutical wholesaler with deep ties to retail pharmacy customers including Walgreens. Comparable in pharmaceutical distribution and broader healthcare services portfolio, though primarily a B2B wholesaler rather than retailer.

Emerging players

• GoodRx: Digital prescription savings platform connecting consumers to discounted drug pricing at partner pharmacies including Walgreens. Comparable digital health marketplace overlap and same channel of competition for cash-paying prescription customers.

Regional players

• LloydsPharmacy: UK-based community pharmacy chain (now largely closed/sold in 2023) historically comparable to Boots and Walgreens UK operations. Direct comp on European community pharmacy model and prescription dispensing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/Walgreens
• YouTubeyoutube.com/user/walgreens
• Facebookfacebook.com/Walgreens
• LinkedInlinkedin.com/company/walgreens-boots-alliance
• Instagraminstagram.com/walgreens/?hl=en
• TikToktiktok.com/@walgreens?lang=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries5 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Walgreens Boots Alliance